FDA Pregnancy Category and Official Guidance
Famciclovir, an antiviral for herpes zoster and genital herpes, is classified as FDA Pregnancy Category B. This means animal studies show no fetal risk, but no adequate human studies exist.[1] The prescribing information states insufficient data on use during pregnancy to assess risks, advising caution and use only if clearly needed.[2]
Evidence from Studies and Registries
Limited human data comes from pregnancy registries and small studies. The Famciclovir Pregnancy Registry (closed 2009) reported no increased birth defect risk among 70 first-trimester exposures, though sample size was too small for firm conclusions.[3] A 2019 review in Obstetrics & Gynecology found no clear teratogenic effects from penciclovir (famciclovir's active metabolite), but called for more research.[4] Acyclovir, a related drug, has stronger safety data in pregnancy and is often preferred.
Risks to Mother and Fetus
Untreated herpes infections pose higher risks during pregnancy, including preterm birth, low birth weight, and neonatal herpes (which can be fatal). Famciclovir suppresses outbreaks, potentially reducing these. No direct fetal harm links to famciclovir in available data, but third-trimester use could lead to low penciclovir levels in breast milk if breastfeeding follows.[5]
When Doctors Recommend It
Physicians weigh benefits against unknowns, often reserving famciclovir for severe recurrent outbreaks unresponsive to alternatives. ACOG guidelines favor suppressive acyclovir or valacyclovir from 36 weeks gestation for herpes simplex to prevent transmission.[6] Consult an OB-GYN; they may monitor via ultrasound or switch drugs.
Alternatives During Pregnancy
- Acyclovir: Category B, extensive safety data, first-line for herpes suppression.
- Valacyclovir: Category B, better oral bioavailability than acyclovir, commonly used.
Avoid topical antivirals alone for systemic infections.
| Drug | Pregnancy Category | Key Notes |
|------|---------------------|-----------|
| Famciclovir | B | Limited human data; use if benefits outweigh risks |
| Acyclovir | B | Preferred; large registry data shows safety |
| Valacyclovir | B | Prodrug of acyclovir; effective for suppression |
What Patients Should Do Next
Discuss with your doctor before starting. Report pregnancy immediately if on famciclovir. Track symptoms and consider herpes vaccination (Shingrix) preconception if eligible.
Sources
[1]: FDA Label for Famvir (famciclovir)
[2]: Famciclovir Prescribing Information
[3]: Famciclovir Pregnancy Registry Final Report
[4]: Antiviral Use in Pregnancy Review (2019)
[5]: CDC Herpes Guidelines
[6]: ACOG Genital Herpes in Pregnancy